Molecular marker for tumordiagnosis and – therapy

Metastasis is the most critical factor responsible for the failure of cancer treatment. Although protein expression profiling, gene array analysis and determination of critical risk factors in tumor tissue have improved the diagnostic classification of tumors, it is still difficult to predict the risk of metastasis by analyzing the resected primary tumor.

A prominent example is the endometrial cancer, which is the seventh most common malignant disorder in females. It affects 142,000 women worldwide, whereas 42,000 die from this cancer. The complete tumor resection survival usually depends on occurence of metastasis. The manifestation of the metastasis can affect different viscera and bones.

Further Information: PDF

IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50

Contact
Dr. Klaus Kobek

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Innovative 3D printed scaffolds offer new hope for bone healing

Researchers at the Institute for Bioengineering of Catalonia have developed novel 3D printed PLA-CaP scaffolds that promote blood vessel formation, ensuring better healing and regeneration of bone tissue. Bone is…

The surprising role of gut infection in Alzheimer’s disease

ASU- and Banner Alzheimer’s Institute-led study implicates link between a common virus and the disease, which travels from the gut to the brain and may be a target for antiviral…

Molecular gardening: New enzymes discovered for protein modification pruning

How deubiquitinases USP53 and USP54 cleave long polyubiquitin chains and how the former is linked to liver disease in children. Deubiquitinases (DUBs) are enzymes used by cells to trim protein…